209 related articles for article (PubMed ID: 36733278)
1. Safety, effectiveness and hesitancy of COVID-19 vaccination in children: A cross-sectional study in Pakistan.
Zaufishan Z; Usman M; Fishan Mumtaz K; Bilal R; Arshad A; Khan HM
Front Public Health; 2022; 10():1084017. PubMed ID: 36733278
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 vaccine hesitancy and attitudes in Pakistan: a cross-sectional phone survey of major urban cities.
Khan AA; Abdullah M; Aliani R; Mohiuddin AF; Sultan F
BMC Public Health; 2023 Jun; 23(1):1112. PubMed ID: 37296386
[TBL] [Abstract][Full Text] [Related]
3. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 vaccination side effects among the child age group: a large cross-sectional online based survey in Saudi Arabia.
Alwafi H; Naser AY; Aldhahir AM; Alhazmi A; Alosaimi AN; Mandili RA; Majeed Z; Salawati E; Ekram R; Samannodi M; Assaggaf H; Almatrafi M; Alqahtani JS; Alsanosi SM; Minshawi F
BMC Infect Dis; 2022 Dec; 22(1):911. PubMed ID: 36474174
[TBL] [Abstract][Full Text] [Related]
5. Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community.
Abukhalil AD; Shatat SS; Abushehadeh RR; Al-Shami N; Naseef HA; Rabba A
BMC Infect Dis; 2023 Jan; 23(1):5. PubMed ID: 36604613
[TBL] [Abstract][Full Text] [Related]
6. Understanding COVID-19 vaccine hesitancy in Pakistan: The paradigm of confidence, convenience, and complacency; A cross-sectional study.
Sheikh NS; Touseef M; Sultan R; Cheema KH; Cheema SS; Sarwar A; Siddique HZ
PLoS One; 2023; 18(8):e0289678. PubMed ID: 37585457
[TBL] [Abstract][Full Text] [Related]
7. From trial to practice: incidence and severity of COVID-19 vaccine side effects in a medically at-risk and vaccine-hesitant community.
Joyce MC; Mountjoy NJ; Johnson JA; Newman JT; Bandy DL; Atalla NA; Singh A; McElroy D
BMC Public Health; 2022 Dec; 22(1):2351. PubMed ID: 36517842
[TBL] [Abstract][Full Text] [Related]
8. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.
Pillay J; Gaudet L; Wingert A; Bialy L; Mackie AS; Paterson DI; Hartling L
BMJ; 2022 Jul; 378():e069445. PubMed ID: 35830976
[TBL] [Abstract][Full Text] [Related]
9. Examination of Adverse Reactions After COVID-19 Vaccination Among Patients With a History of Multisystem Inflammatory Syndrome in Children.
Elias MD; Truong DT; Oster ME; Trachtenberg FL; Mu X; Jone PN; Mitchell EC; Dummer KB; Sexson Tejtel SK; Osakwe O; Thacker D; Su JA; Bradford TT; Burns KM; Campbell MJ; Connors TJ; D'Addese L; Forsha D; Frosch OH; Giglia TM; Goodell LR; Handler SS; Hasbani K; Hebson C; Krishnan A; Lang SM; McCrindle BW; McHugh KE; Morgan LM; Payne RM; Sabati A; Sagiv E; Sanil Y; Serrano F; Newburger JW; Dionne A;
JAMA Netw Open; 2023 Jan; 6(1):e2248987. PubMed ID: 36595296
[TBL] [Abstract][Full Text] [Related]
10. Side effects after COVID-19 vaccinations among residents of Poland.
Andrzejczak-Grządko S; Czudy Z; Donderska M
Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4418-4421. PubMed ID: 34227078
[TBL] [Abstract][Full Text] [Related]
11. Knowledge, attitude, and practices of front line health workers after receiving a COVID-19 vaccine: a cross-sectional study in Pakistan.
Minhas S; Sajjad A; Manzoor I; Masood A; Suhail A; Shaikh GM; Kashif M
PeerJ; 2023; 11():e14727. PubMed ID: 36935914
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada.
Buchan SA; Seo CY; Johnson C; Alley S; Kwong JC; Nasreen S; Calzavara A; Lu D; Harris TM; Yu K; Wilson SE
JAMA Netw Open; 2022 Jun; 5(6):e2218505. PubMed ID: 35749115
[TBL] [Abstract][Full Text] [Related]
13. Post COVID-19 vaccination side effects and associated factors among vaccinated health care providers in Oromia region, Ethiopia in 2021.
Segni MT; Demissie HF; Adem MK; Geleto AK; Kelkile MW; Sori BK; Heyi ML; Iticha DG; Bejiga GS; Guddisa AB; Sima YA; Amente LT; Bayisa DA; Hurisa MB; Jiru TK
PLoS One; 2022; 17(12):e0278334. PubMed ID: 36480564
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 vaccine hesitancy and social contact patterns in Pakistan: results from a national cross-sectional survey.
Quaife M; Torres-Rueda S; Dobreva Z; van Zandvoort K; Jarvis CI; Gimma A; Zulfiqar W; Khalid M; Vassall A
BMC Infect Dis; 2023 May; 23(1):321. PubMed ID: 37170085
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 vaccine safety and side effects in children aged 5-11 years: a cross-sectional study.
Nurhani MA; Farah HMS; Ili NMA; Zahidah AR; Rahimah B; Nabilah HK; Gan LL; David NCE
Med J Malaysia; 2023 Nov; 78(6):803-807. PubMed ID: 38031224
[TBL] [Abstract][Full Text] [Related]
16. Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): A cross-sectional study.
Massoud F; Ahmad SF; Hassan AM; Alexander KJ; Al-Hashel J; Arabi M
Seizure; 2021 Nov; 92():2-9. PubMed ID: 34391030
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
18. Covid-19 vaccination reported side effects and hesitancy among the Syrian population: a cross-sectional study.
Najjar M; Albuaini S; Fadel M; Mohsen F; ; Najjar G; Assaf D; Aljbawi A; AlAwad Y
Ann Med; 2023; 55(2):2241351. PubMed ID: 37544017
[TBL] [Abstract][Full Text] [Related]
19. A qualitative insight into the perceptions and COVID-19 vaccine hesitancy among Pakistani pharmacists.
Yaseen MO; Saif A; Khan TM; Yaseen M; Saif A; Bukhsh A; Shahid MN; Alsenani F; Tahir H; Ming LC; Amin MU; Suleiman AK; Al-Worafi YM; Baig MR; Saeed Imran M; Jaber AA
Hum Vaccin Immunother; 2022 Dec; 18(1):2031455. PubMed ID: 35192781
[TBL] [Abstract][Full Text] [Related]
20. Acceptance Rates and Beliefs toward COVID-19 Vaccination among the General Population of Pakistan: A Cross-Sectional Survey.
Yasmin F; Asghar W; Babar MS; Khan H; Ahmad S; Hameed Z; Asghar MS; Nauman H; Khattak AK; Arshad Z; Shah SMI; Siddiqui SA; Osama M; Zarak MS
Am J Trop Med Hyg; 2021 Sep; 105(5):1230-1239. PubMed ID: 34525449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
